Biotech News

FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints

Boston Scientific (BSX)Boston ScientificClinical readout

BSX (BSX) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is bsx.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

Boston Scientific

Global Medical Technology Platform Boston Scientific is a global medical technology company with products spanning cardiovascular care, endoscopy, urology, neuromodulation, interventional oncology, respiratory care, and gastrointestinal medicine. Its portfolio centers on high-performance devices and minimally invasive therapies designed...

Recent company news

Stock data

Close
49.30 USD
Market cap
70.87B USD
Exchange
NYSE
Sector
Biopharma
Location
United States